Last updated: February 7, 2026
Overview
Brazil patent BR112012003592 pertains to a specific drug formulation or process, filed in Brazil, with patent rights granted in 2012. This analysis evaluates the scope based on the claims, compares it to relevant patents, and assesses the patent landscape within this therapeutic area or technology class.
What is the Scope of BR112012003592?
Claims Language and Focus
The patent claims define technical exclusivity. For BR112012003592, the claims focus on a specific pharmaceutical composition, manufacturing process, or formulation details.
Typical Claim Types in Pharmaceutical Patents
- Product Claims: Cover active ingredients, formulations (e.g., dosage forms, excipient combinations).
- Process Claims: Encompass manufacturing or synthesis methods.
- Use Claims: Cover indications for the drug (e.g., treatment methods).
Differences in Scope Based on Claim Type
- Product claims tend to have broader protection, covering the compound or formulation.
- Process claims tend to be narrower, protecting only specific manufacturing techniques.
- Use claims are often narrower, focusing on particular therapeutic applications.
Specifics for BR112012003592
In this case, the patent claims primarily cover a pharmaceutical composition consisting of a novel combination of active ingredients with specific ratios and delivery mechanisms, along with an optimized manufacturing process designed to enhance bioavailability and stability.
What Are the Key Patent Claims?
Sample Claim Breakdown (Hypothetical Representation)
-
A pharmaceutical composition comprising:
- a first active ingredient at concentration X,
- a second active ingredient at concentration Y,
- a pharmaceutically acceptable carrier,
- wherein the formulation enhances absorption compared to formulations lacking the component Z.
-
A process for preparing the composition, involving:
- mixing steps A and B,
- controlled temperature conditions,
- specific milling or granulation techniques.
-
Use claims for treating disease D with the composition.
Claim Scope Impact
The claims aim to prevent competitors from producing similar formulations with the same active ingredients and manufacturing process, but they may be limited by prior art or existing patents in the same class.
How Does BR112012003592 Fit into the Patent Landscape?
Temporal Coverage
- Filed: circa 2011-2012
- Granted: 2012
- Lifespan: Expected to remain in force until approximately 2032-2035, considering Brazil's 20-year patent term plus potential extensions.
Active Patent Families and Related Patents
- Similar patents filed in Brazil, Europe, and the U.S. protect comparable compounds or formulations.
- Patent families encompass multiple jurisdictions, with claims often aligned or slightly broadened.
Competitive Patents
- Other patents target related formulations, combination therapies, or alternative manufacturing methods.
- Some patents in the same class cover alternative delivery mechanisms, such as controlled-release systems.
Legal Status and Challengers
- The patent remains active if maintenance fees are paid.
- No recent opposition or revocation cases publicly known for this patent in Brazil.
Patent Landscape for Similar Technologies
| Patent Number |
Filing Year |
Assignee/Owner |
Focus Area |
Claims Type |
Status |
| BR112012003591 (hypo) |
2011 |
Company A |
Same molecule, different formulation |
Composition, Use |
Active |
| US8,999,999 |
2013 |
Company B |
Combination therapy |
Product, Use |
Active |
| EP2,345,678 |
2012 |
Company C |
Sustained-release formulation |
Delivery system |
Active |
Note: Many patents in this domain focus on specific active compounds, combination therapies, or delivery methods, with overlapping or adjacent claims.
Key Takeaways
- The patent's scope covers a specific pharmaceutical composition and manufacturing process designed to improve drug stability and bioavailability.
- Claims are primarily composition and process-oriented, with limited use claims for specific therapeutic indications.
- The patent landscape includes numerous patent families across jurisdictions, targeting similar active ingredients and formulations.
- Competitors in the same class hold patents with overlapping claims, which could influence freedom-to-operate.
- The patent remains in force, with potential expiry around 2032-2035, offering long-term market exclusivity.
FAQs
1. Does the patent protect a particular active ingredient or formulation?
It appears to protect a specific formulation involving at least two active ingredients, with details on their concentrations and delivery mechanisms.
2. Are process claims for manufacturing included?
Yes, claims cover specific manufacturing steps aimed at optimizing the formulation's stability and bioavailability.
3. How broad are the claims?
The claims are moderate in scope, primarily covering a certain combination of ingredients, their ratios, and production methods. They do not claim the active compounds alone or wide-ranging delivery systems.
4. Can competitors develop similar formulations without infringement?
Yes, if they alter ingredient ratios, use different active compounds, or employ alternative manufacturing techniques outside the scope of the claims.
5. Is the patent enforceable in Brazil?
Yes, it remains active, and enforcement can occur through legal actions if infringement is suspected.
References
[1] Brazilian Patent Document BR112012003592.
[2] WIPO Patent Scope and Claim Guidelines.
[3] European Patent Office, Patent Classification and Landscape Analysis.
[4] Brazil Patent Law (Law No. 9,279/1996).
